Header cover image

Swiss Pharmaceuticals & Biotech Potentially Undervalued Companies

UPDATED Oct 01, 2023

Companies with a Value score of at least 3, ordered by Value score

32 companies
CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield
QGENQiagenUS$48.850%0%US$9.2bUS$63.08PE18.9xE5.9%n/a
EVTEvotec€27.760%1.1%€3.3b€40.99PS4.2xE59.6%n/a
LONNLonza GroupCHF425.60-1.5%-13.3%CHF31.6bCHF627.41PE28xE14.7%0.8%
BMYBristol-Myers SquibbUS$54.240%0%US$121.3bUS$67.73PE15.2xE14.2%3.9%
BIIBBiogenUS$222.000%0%US$37.2bUS$282.90PE14xE4.9%n/a
TEVATeva Pharmaceutical IndustriesUS$7.850%0%US$11.4bUS$8.16PB1.6xE65.1%0%
1102657GSKUK£26.120%-2.8%UK£70.6bUK£34.09PE13.8xE8.9%5.7%
ROGRoche HoldingCHF250.450.4%-22.2%CHF202.0bCHF313.40PE18.1xE10.5%3.8%
GXIGerresheimer€75.600%0%€3.4b€105.83PE32.2xE23.7%1.3%
RORoche HoldingCHF269.400.7%-30.2%CHF202.0bCHF337.12PE18.1xE10.5%3.8%
ESFEurofins Scientific€505.000%0%€11.7b€550.95PE20.1xE4.7%1.7%
BSLNBasilea PharmaceuticaCHF41.00-3.0%-0.2%CHF491.2mCHF70.44PE8.7xE19.1%0%
2HQTilray BrandsUS$46.280%0%US$1.7bUS$56.82PS2.8xE116.6%n/a
LONNELonza GroupCHF428.90-0.8%n/aCHF31.6bCHF632.28PE28xE14.7%0.8%
NOVNNovartisCHF93.871.5%23.5%CHF194.1bCHF102.53PE27.7xE12.2%3.3%
935700Gilead SciencesUS$68.480%10.5%US$94.1bUS$82.84PE17.2xE7.8%4.0%
907582AmgenUS$226.360%n/aUS$143.8bUS$221.00PE18xE1.6%3.2%
BAYNBayer€200.000%0%€44.7b€290.43PE30.8xE25.4%5.3%
JCAREJoincare Pharmaceutical Group IndustryLtdCN¥8.000%-44.1%CN¥23.1bCN¥9.50PE15.2xE16.9%1.5%
SFZNSiegfried HoldingCHF784.501.4%8.2%CHF3.3bCHF871.88PE22.4xE10.2%0.4%
PPGNPolyPeptide GroupCHF16.72-2.5%-41.9%CHF550.8mCHF20.52PS2xE67.1%0%
NOVNEENovartisCHF94.091.8%23.9%CHF194.1bCHF102.77PE27.7xE12.2%3.3%
MERMERCK Kommanditgesellschaft auf Aktien€168.090%n/a€79.8b€191.28PE24.1xE6.1%1.0%
MORMorphoSys€102.000%0%€882.6m€124.83PE10xE2.6%n/a
Page 1 of 2